Walter Schmidt
Direktor/Vorstandsmitglied bei Advantage Therapeutics, Inc.
Profil
Walter Schmidt currently works at ADvantage Therapeutics, Inc., as Director & Director-mRNA Division.
Aktive Positionen von Walter Schmidt
| Unternehmen | Position | Beginn |
|---|---|---|
Advantage Therapeutics, Inc.
 Advantage Therapeutics, Inc. Medical SpecialtiesHealth Technology ADvantage Therapeutics, Inc. is an American biotech company that focuses on developing therapies to treat neurodegenerative conditions, specifically Alzheimer's disease. The company was founded in 2021 and is based in an undisclosed location. The company's subsidiary, ADvantage Therapeutics GmbH, conducts early research and drug development. The company is developing a novel immunotherapy for early Alzheimer's disease. The company was founded by Jeffrey Bartley Madden and Agustin Fernandez Santana, with Jeffrey Bartley Madden serving as the CEO since incorporation. | Direktor/Vorstandsmitglied | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
Advantage Therapeutics, Inc.
Advantage Therapeutics, Inc. Medical SpecialtiesHealth Technology ADvantage Therapeutics, Inc. is an American biotech company that focuses on developing therapies to treat neurodegenerative conditions, specifically Alzheimer's disease. The company was founded in 2021 and is based in an undisclosed location. The company's subsidiary, ADvantage Therapeutics GmbH, conducts early research and drug development. The company is developing a novel immunotherapy for early Alzheimer's disease. The company was founded by Jeffrey Bartley Madden and Agustin Fernandez Santana, with Jeffrey Bartley Madden serving as the CEO since incorporation. | Health Technology |
